Galaxy Biomedical announced that at annual general meeting held on May 12, 2017, the shareholders approved the election of Tang Xinlin, Xu Hongjun, Ye Debin and Wang Su as non-independent directors; Chen Lihua, Liang Feng and Jiang Qingyun as independent directors.